Clinical Trials Browser

Phase 1 × pevonedistat × 90 days × Clear all

NCT03479268 2026-04-27

Pevonedistat and Ibrutinib in Treating Participants With Relapsed or Refractory CLL or Non-Hodgkin Lymphoma

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Prolymphocytic, B-Cell

NCT03009240 2026-04-22

Pevonedistat and Decitabine in Treating Patients With High Risk Acute Myeloid Leukemia

Phase 1 Completed

12 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute